Table 3 . Overuse categories .
| Overuse category | Percentage | |
| Overuse of indication | 59.2% | |
| Overuse of duration | 22.1% | |
| Overuse of dosage | Overuse of dosage in reflux disease | 4.2% |
| Overuse of dosage in other than reflux disease | 14.5% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.